⌘K

Login Start Free

Home/Filings/4/0001214659-20-001605

4//SEC Filing

SAMANT VIJAY B 4

Accession 0001214659-20-001605

CIK 0000819050other

View on SEC.gov Company Profile

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 5:06 PM ET

Size

8.6 KB

Accession

0001214659-20-001605

Insider Transaction Report

Form 4

Period: 2020-02-14

Brickell Biotech, Inc.BBI

DirectorPresident & CEO

Transactions

Award
Stock Options
2020-02-14$1.16/sh+7,328$8,500→ 7,328 total
Exercise: $1.16From: 2020-02-14Exp: 2030-02-13→ Common Stock (7,328 underlying)
Award
Restricted Stock Units
2020-02-14$1.16/sh+2,167$2,514→ 2,167 total
Exercise: $1.16From: 2020-02-14Exp: 2030-02-13→ Common Stock (2,167 underlying)

Holdings

Nonstatutory Stock Option (right to buy)
Exercise: $1.81From: 2018-06-18Exp: 2028-01-07→ Common Stock (105,000 underlying)
105,000

Documents

1 file

4
marketforms-47813.xmlPrimary
PRIMARY DOCUMENT

Issuer

Brickell Biotech, Inc.

CIK 0000819050

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001198238

Filing Metadata

Form type: 4
Filed: Feb 18, 7:00 PM ET
Accepted: Feb 19, 5:06 PM ET
Size: 8.6 KB

View on SEC.gov